Cytek Biosciences, Inc. (CTKB) Misses Q2 EPS by 1c
Tweet
Share
E-mailGet Alerts CTKB Hot Sheet
Join SI Premium – FREE
Cytek Biosciences, Inc. (NASDAQ: CTKB) reported Q2 EPS of ($0.09), $0.01 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $48.1 million versus the consensus estimate of $48.61 million.
For earnings history and earnings-related data on Cytek Biosciences, Inc. (CTKB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nebius soars on second quarter revenue beat
- Kamada Ltd. (KMDA) Tops Q2 EPS by 4c
- Humacyte, Inc. (HUMA) Misses Q2 EPS by 7c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
